Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Dividend Declaration

26 Nov 2020 17:06

RNS Number : 6860G
Compagnie de Saint-Gobain
26 November 2020
 

PRESS RELEASE

 

 

November 26, 2020

 

SHAREHOLDER RETURN POLICY

 

As announced in April of this year, the Board of Directors has reviewed the Group's shareholder return policy.

 

Based on the sales and results growth in the third quarter and the good start to the fourth quarter, the Group's operating income for second-half 2020 will increase on a like-for-like basis compared to second-half 2019.

 

In view of these results, the Board intends to recommend to the June 3, 2021 Shareholders' Meeting that it sets the dividend in respect of 2020 - payable in June 2021 - at €1.33 per share to be paid in cash, i.e., at the level of the dividend paid in June 2019.

 

The Board of Directors has moreover confirmed that it will maintain its policy of privileging a dividend in cash targeting a normalized dividend payout rate representing between 35% and 40% of recurring net income, a rate that will be exceeded for the dividend payable in respect of 2020.

 

The Group also announces that it has reached its medium-term objective of a reduction in the number of shares outstanding to 530 million, from 542 million at December 31, 2019.

 

 

ABOUT SAINT-GOBAIN

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change.

 

€42.6 billion in sales in 2019Operates in 70 countriesMore than 170,000 employees

 

For more information about Saint-Gobain

Visit www.saint-gobain.com

and follow us on Twitter @saintgobain

 

 

 

Analyst/Investor relations

 

 

Press relations

Vivien Dardel

Floriana Michalowska

Christelle Gannage

 +33 1 88 54 29 77

 +33 1 88 54 19 09

 +33 1 88 54 15 49

Laurence Pernot

Patricia Marie

Susanne Trabitzsch

+33 1 88 54 23 45

+33 1 88 54 26 83

+33 1 88 54 27 96

 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAXFKAELEFFA
Date   Source Headline
6th Jan 20265:00 pmRNSIntention to delist from the London Stock Exchange
5th Jan 20267:19 amRNSAcquisition
8th Dec 20257:38 amRNSSaint-Gobain cancels 4.2 million shares
1st Dec 20254:58 pmRNSDisposal
30th Oct 20255:54 pmRNS3rd Quarter Results
6th Oct 20257:40 amRNSCapital Markets Day
2nd Oct 20255:10 pmRNSDisposal
1st Oct 20255:08 pmRNSDisposal
26th Sep 20255:14 pmRNSNew plant
8th Sep 20255:12 pmRNSNew construction chemicals organization in Germany
20th Aug 20257:15 amRNSDisposal
31st Jul 20255:51 pmRNSHalf-year Report
29th Jul 20255:10 pmRNSAcquisition
8th Jul 20255:10 pmRNSDisposal
18th Jun 20255:06 pmRNSAcquisition
5th Jun 20256:11 pmRNSNew organization
5th Jun 20255:53 pmRNSAGM Statement
4th Jun 20257:17 amRNSNew plant
20th May 20255:12 pmRNSNew plant
24th Apr 20255:31 pmRNS1st Quarter Results
22nd Apr 20257:00 amRNSSaint-Gobain featured on CDP’s “Climate A List”
26th Mar 20257:00 amRNSBond issue
27th Feb 20255:45 pmRNSAnnual Financial Report
21st Feb 20257:10 amRNSAppointment
10th Feb 20257:12 amRNSAcquisition
4th Feb 20254:54 pmRNSProduction line
16th Jan 20255:41 pmRNSFacility
15th Jan 20255:26 pmRNSAcquisition
3rd Dec 20245:26 pmRNSDecrease in capital
3rd Dec 20247:04 amRNSAcquisition
2nd Dec 20245:10 pmRNSAcquisition
2nd Dec 20247:06 amRNSDisposal
28th Nov 20245:15 pmRNSGovernance
7th Nov 20247:12 amRNSAgreement
29th Oct 20245:55 pmRNS3rd Quarter Results
14th Oct 20245:07 pmRNSAcquisition
8th Oct 20247:05 amRNSAgreement
10th Sep 20245:13 pmRNSDisposal
2nd Sep 20247:06 amRNSDisposal
15th Aug 20246:14 pmRNSAcquisition
31st Jul 20246:07 pmRNSIssue of Debt
26th Jul 20247:00 amRNSHalf-year Report
9th Jul 20247:08 amRNSAcquisition
27th Jun 20247:00 amRNSAcquisition
7th Jun 20247:00 amRNSAGM Statement
3rd Jun 20245:18 pmRNSAcquisition
2nd May 20245:34 pmRNSAgreement
25th Apr 20245:16 pmRNS1st Quarter Results
3rd Apr 20245:44 pmRNSAcquisition
26th Mar 20246:01 pmRNSIssue of Debt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.